Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | GABRP | O00591 | 2/20 | 0.32 |
| ▸ | GABRD | O14764 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.32 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.32 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.32 |
| ▸ | GABRE | P78334 | 2/20 | 0.32 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.32 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.32 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.32 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8749213 | 1.00 | KMT2A (0.35) | KMT2AALOX15BLMPMP22GABRP | |
| SCHEMBL27754880 | 0.84 | KMT2A (0.32) | KMT2AALOX15BLMPMP22MEN1 | |
| SCHEMBL27798308 | 0.82 | — | — | |
| SCHEMBL5582239 | 0.79 | KMT2A (0.37) | KMT2AALOX15BLMPMP22MEN1 | |
| SCHEMBL9759339 | 0.77 | CYP1A2 (0.46) | KMT2AALOX15BLMPMP22GABRP | |
| SCHEMBL9759465 | 0.77 | CYP1A2 (0.46) | KMT2AALOX15BLMPMP22GABRP | |
| SCHEMBL4278882 | 0.76 | ODC1 (0.41) | KMT2AALOX15BLMPMP22MEN1 | |
| SCHEMBL4278883 | 0.76 | ODC1 (0.41) | KMT2AALOX15BLMPMP22MEN1 | |
| SCHEMBL8770534 | 0.76 | KMT2A (0.36) | KMT2AALOX15BLMPMP22MEN1 | |
| SCHEMBL11867055 | 0.76 | KMT2A (0.36) | KMT2AALOX15BLMPMP22MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107805275-B | Novel N (2) -L-alanyl-L-glutamine crystal form and preparation method thereof | 重庆莱美隆宇药业有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-115974961-A | Process for producing N (2) -L-alanyl-L-glutamine | 重庆奥凯科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115317590-A | Compound amino acid injection and application and preparation method thereof | 北京世桥生物制药有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-111088221-B | Composition for promoting sperm activation, sperm activating solution and preparation method thereof | 成都艾伟孚生物科技有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-111518749-B | In-vitro culture solution for immature oocyte, preparation method and application thereof | 成都艾伟孚生物科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-111518749-A | In-vitro culture solution for immature oocyte, preparation method and application thereof | 成都艾伟孚生物科技有限公司 | 2020-08-11 | — | — | CN | claimed |
| CN-106806884-B | N (2) -L-alanyl-L-glutamine injection and preparation method thereof | 武汉大安制药有限公司 | 2020-06-19 | — | — | CN | claimed |
| CN-111088221-A | Composition for promoting sperm activation, sperm activating solution and preparation method thereof | 成都艾伟孚生物科技有限公司 | 2020-05-01 | — | — | CN | claimed |
| CN-106565821-B | N (2) -L-alanyl-L-glutamine novel crystal form and preparation method thereof | 珠海同源药业有限公司 | 2020-04-10 | — | — | CN | claimed |
| CN-103265616-A | N(2)-L-alanyl-L-glutamine synthesis method | BAODING LONGRUI PHARMACEUTICAL TECHNOLOGY CO LTD | 2013-08-28 | — | — | CN | claimed |
| CN-101229185-A | Medicine compounds for treating seriously disease | BEIJING FRESENIUS KABI PHARMAC (CN) | 2008-07-30 | — | — | CN | claimed |
| CN-101062938-A | Process for producing N (2) -L-alanyl-L-glutamine | FUJIAN SANAI PHARMACEUTICAL CO (CN) | 2007-10-31 | — | — | CN | claimed |
| CN-101049500-A | Composition of amino acid | SULIMAN MEDICAL TECH CO LTD BE (CN) | 2007-10-10 | — | — | CN | claimed |
| CN-1302008-C | Synthetic method for N(2)-L-alanyl-L-glutamine dipeptide | UNIV XIAMEN (CN) | 2007-02-28 | — | — | CN | claimed |
| CN-1683391-A | Synthetic method for N(2)-L-alanyl-L-glutamine dipeptide | UNIV XIAMEN (CN) | 2005-10-19 | — | — | CN | claimed |
| CN-1679531-A | N(2)-L-alanyl-L-glutamine aseptic powdery preparation and process for prepairing same | ZHICHENG MEDICAL SCIENCE AND T (CN) | 2005-10-12 | — | — | CN | claimed |
| CN-1602850-A | N(2)-L-alanyl-L-glutamine injection and its preparation method | TAO LINGGANG (CN) | 2005-04-06 | — | — | CN | claimed |
| EP-0571198-B1 | Cosmetic composition containing hair-growth promoter | UNILEVER PLC (GB) | 1997-03-19 | — | — | EP | claimed |
| US-5559092-A | HAIR GROWTH, GLUTAMINE DIPEPTIDE | CHESEBROUGH-POND'S USA CO. DIVISION OF CONOPCO, INC. (US) | 1996-09-24 | — | — | US | claimed |
| EP-0571198-A1 | Cosmetic composition containing hair-growth promoter | UNILEVER PLC (GB) | 1993-11-24 | — | — | EP | claimed |